Image Source: AsiaOne
ROSEN, A LEADING LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important February 28 Deadline in Securities Class Action – INSD, MZKRGlobeNewswireJanuary 22, 2022NEW YORK, Jan. 22, 2022 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., January 22, 2022. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTCMKTS: INSD; MZKR) between December 8, 2020 and November 24, 2021, inclusive (the "Class Period"), of the important February 28, 2022 lead plaintiff deadline. SO WHAT: If you purchased Instadose securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Source: AsiaOne